Alvotech (ALVO) 2025 Conference June 05, 2025 10:30 AM ET Speaker0 All righty. Good morning, and welcome to Jefferies Global Healthcare Conference. My name is Matthew Pakora with the Jefferies Healthcare Investment Banking team, and it's my great pleasure to introduce you to Doctor. Balaji Prasad, the Chief Strategy Officer. He will get us started here today. Speaker1 Thank you, Matthew. Good morning, everyone. My name is Balaji Prasad, the Chief Strategy Officer at Talvotech. It's my pleasure to present th ...

THIS PRESS RELEASE MAY NOT BE DISTRIBUTED, RELEASED, OR PUBLISHED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEELAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, RUSSIA, BELARUS, OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE UNLAWFUL OR DEMAND ADDITIONAL REGISTRATION OR OTHER MEASURES. PLEASE REFER TO “IMPORTANT INFORMATION” IN THE END OF THIS PRESS RELEASE. Alvotech has carried out a private placement of 7 ...

Not to be released, published, distributed or circulated in any jurisdiction in which it would be unlawful to do so. This press release is for information purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities. REYKJAVIK, ICELAND AND STOCKHOLM, SWEDEN (May 19, 2025) — On May 16, 2025 Alvotech (NASDAQ: ALVO, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced the ...